The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
VJVirtual | Glycosylation of immunoglobulin light chains in CAD
In this interview, Surbhi Sidana, MD, of the Mayo Clinic, Stanford, CA, discusses glycosylation of immunoglobulin as it relates to cold agglutinin disease (CAD) and how this can signify a risk for amyloidosis development. In this discussion, glycosylation is evaluated as a diagnostic tool for this indication. This interview was recorded via an online conference call with the Video Journal of Hematological Oncology (VJHemOnc).
